94% of patients with cancer respond well to COVID-19 vaccines
In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients ...
Jul 1, 2021
0
2
